Controversy about whether there are microbes in the placenta and if they have any functional importance during pregnancy and for neonatal health is ongoing. Previous work has demonstrated that the basal plate (BP), comprising maternal and fetal derived cells harbors intracellular bacteria. 16S sequencing and bacterial species-specific analysis of term placentas revealed that the gram-negative bacillus Ralstonia insidiosa, native to aqueous environments and an effective biofilm promoter, comprises the most abundant species in the BP. Here, we demonstrate whether R. insidiosa cells home to a particular niche in the BP, how they may arrive there, and whether they are associated with adverse outcomes. We developed methods to detect and study cell-specific localization of R.
Introduction
Throughout pregnancy, the fetus relies on the placenta for communication with the mother and transport of nutrients and wastes. Additionally, the placenta provides a barrier against ascending and hematogenously transmitted infections. Most microorganisms cannot penetrate the placenta, though some can bypass placental defenses, leading to local or systemic immune activation and adverse outcomes such as preterm birth or fetal death 1 . Thus, the healthy uterus has long been considered a sterile environment 2 .
Contrary to this paradigm, bacterial DNA has been identified in the amniotic fluid and meconium, suggesting that the womb may not be sterile after all [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . More recently, studies have detected bacteria in term placentas 11,18-24 . For example, our histological analysis revealed the presence of both gram-positive and gram-negative intracellular bacteria, sometimes in biofilm-like clusters of bacilli, in the human placental basal plate (BP), which contains both fetal and maternal cells 23 . Seferovich and colleagues further validated the presence of bacteria from term and preterm placentas, without evidence of maternal infection, using 16S in situ hybridization, histologic staining methods, and clinical culturing methods 22 . Additionally, several investigators have used culture-independent sequencing methods to identify bacterial DNA in term and preterm human placentas 18, 22, 25, 26 and other fetal or maternal conditions including low birth-weight 27 , preeclampsia 28 , maternal obesity 29 , and gestational diabetes 30 .
We previously performed 16S ribosomal RNA (rRNA) sequencing to interrogate the microbial profiles at various sites in full term placentas from uncomplicated pregnancies. These sites include the maternal compartment, comprised of the BP, and the fetal compartment, comprised of the placental villi (PV) and fetal membranes (FM).
We found that Ralstonia insidiosa (R. insidiosa), a gram-negative, aerobic, motile bacillus, is most prevalent in the BP 19 . R. insidiosa was first isolated from the sputum of cystic fibrosis patients and can be isolated from immunocompromised patients in hospitals 31, 32 .
However, this bacterium is also found in pond water, soil, sludge 33 , fresh-cut produce facilities 34 , water distribution systems 35 , and dispensed water used for bottled water 36 .
Because R. insidiosa can form biofilms 34, 37 , is multi-drug resistant, and can survive sterilization methods 38 , it may pose a health threat to some individuals 39 .
Here, we sought to determine whether or not R. insidiosa is present at the maternal-fetal interface and its potential relevance in this niche. We report that we can identify R. insidiosa by fluorescent in situ hybridization (FISH) in human placental BP biopsies. Additionally, we show that R. insidiosa can enter and replicate within human trophoblasts ex vivo. Further, we show that R. insidiosa replicates in a model of extravillous trophoblasts (EVTs) in an in vitro setting, but it does not cause cell death or activate a pro-inflammatory immune responses. Finally, we show that R. insidiosa can enter the mouse placenta when delivered via the intrauterine route, though it does not cause preterm labor. Our findings support the idea that R. insidiosa can colonize the placenta but is likely not a threat to placental health. Here, we report R. insidiosa as a bona fide resident in the maternal-fetal interface.
Results

R. insidiosa is detected in term BP specimens
Due to lack of availability of antibodies to detect R. insidiosa in preserved tissue, we developed FISH probes that could be used on placentas. We used the DesignProbes package in Decipher 40 , which assesses specificity and calculates potential crosshybridization species, to design a species-specific probe for R. insidiosa. The specificity of this probe was confirmed by growing the R. insidiosa reference strain (MJ602) in culture and performing FISH with either a bacterial-domain probe (Bacteria -EUB338-CY3) and a species-specific R. insidiosa probe (Figure S1 A-D), a R. insidiosa probe alone (Figure S1 E-H), or a non-sense negative control probe (Non-bacterial -NON-EUB338) and bacterial probe (Figure S1 I-L). The species-specific probe, with and without the application of the bacterial probe, hybridized as expected using the reference R. insidiosa strain. Failure to detect the non-specific nonsense probe confirmed the functionality of the bacterial probe for our study (Figure S1 I-L). The probes and the bacteria used in this study are presented in Tables S1 and S2, respectively.
Next, we tested whether R. insidiosa could be detected in BP biopsies from our previous study ( Table 1) . 11 BP samples from term pregnancies were tested. We also stained the samples with an antibody to histocompatibility complex-G (HLA-G), a marker of EVTs within the BP (Figure 1 A-B ). Bacteria were detected in the BP with both the bacterial probe (Figure 1 
R. insidiosa can colonize BP explants and EVTs
We previously reported that, when added to BP explants cultured ex vivo, grampositive and negative bacteria replicate and aggregate within EVTs 41 . These epithelial cells extravasate from the placental villi into the BP to anchor the fetal compartment to the maternal side of the placenta. This event both remodels spiral arteries and facilitates blood circulation within the intervillous space 42 . We wondered whether R. insidiosa could also invade and replicate within BPs, and specifically, within EVTs. In addition to the WT R. insidiosa strain (MJ602), we generated yfp-expressing R. insidiosa strain (GGW102) to localize R. insidiosa within BP explants (Table S2) . Species-specific FISH probes effectively hybridized to GGW102 (Figure S2 A-L) . Additionally, we confirmed that it expressed yfp using a panel of YFP-specific qPCR primers generated commercially (Figure S2 M; Table S3 ). R. insidiosa WT (MJ602) and yfp-tagged (GGW102) isolates were cultured for over the course of 24 hours to monitor growth patterns ( Figure S3 ). We did not see a significant difference in the log colony forming units (CFUs) between isolates after 4 hours, indicating that MJ602 or GGW102 could be used interchangeably to assess R. insidiosa growth.
Fresh biopsies from placentas from term uncomplicated pregnancies delivered vaginally or by Caesarean section were incubated with 1x10 8 CFUs of R. insidiosa yfpstrain (GGW102) for 8 hours. The explants remained morphologically intact, suggesting that R. insidiosa caused no major cell damage (Figure S2 A-B) . Species-specific FISH Next, we wondered whether R. insidiosa proliferates within the BP cells. Because R. insidiosa is resistant to gentamicin (data not shown and 38 ), the standard gentamicin protection assay could not be used to assess intracellular bacterial replication. Instead, we incubated the explants with 1x10 8 CFU of R. insidiosa for 2, 8, and 24 hours. At each time point, explants were extensively washed, homogenized, and quantified for adhered and invaded bacteria using CFU analysis. We found that the R. insidiosa CFUs increased approximately ten-fold from 2 to 24 hours, suggesting that the bacteria replicated either within or on BP explant cells (Figure 2 G) . In conjunction with TEM, this indicates that R. insidiosa replicates intracellularly within BP cells.
To directly address whether R. insidiosa could invade EVTs, we used the JEG-3 choriocarcinoma line. JEG-3 cells have a similar gene expression profile to normal EVTs 43, 44 and have been used as a model to study pathogen-EVT interactions in the placenta 45 . We challenged JEG-3 cells with R. insidiosa at multiple doses and quantified bacterial invasion and adhesion. Although R. insidiosa could adhere to and invade JEG-3 cells, it did not do so in a dose-dependent manner (Figure 3 A) . Similar to R. insidiosa-challenged BP cells, TEM analysis of JEG-3 cells revealed single R. insidiosa within singlemembrane vacuoles (Figure 3 B-F) . In some cases, multiple R. insidiosa rods existed within a single vacuole. These vacuoles were reminiscent of Listeria monocytogenescontaining vacuoles recently reported by Kortebi and colleagues 46 (Figure 3 
G-I).
To determine the impact of R. insidiosa on EVTs, we first assessed cell viability by quantifying lactate dehydrogenase, which is released upon cell death in media. Whereas R. insidiosa caused no JEG-3 cell death (Figure 3 J) , challenge with L. monocytogenes did cause cell death in a dose-dependent manner (Figure 3 K) . Next, we asked whether EVTs mount inflammatory responses when exposed to R. insidiosa. To answer this question, we challenged JEG-3 cells with R. insidiosa for 8 hours and then evaluated expression of the pro-inflammatory immune marker NF-κB and the secretion of the pro- 
R. insidiosa is detectable and cultivable in the murine placenta
How bacteria reach the placenta has not been fully determined. Several studies have reported that non-pathogenic microbes in the placenta are most similar to those found in the oral mucosa 18, 29, 48 . For example, the oral bacterium Fusobacterium nucleatum has been isolated from the placenta and amniotic fluid 49 . Thus, we investigated possible sources of R. insidiosa within the placenta. We performed metaanalysis of the Human Microbiome dataset and found Ralstonia spp. in niches associated with the oral mucosa including the hard palate, saliva, and throat (Figure 4 A) . Ralstonia was also detected in the anterior nares and left and right retroauricular crease and antecubital fossa (data not shown). In contrast, Ralstonia was found at low abundance in stool.
Given that Ralstonia spp. have been detected in oral niches and has been found in fresh-cut produce facilities 34 , water distribution systems 35 , and bottled water 50,51 , we hypothesized that this bacterium could reach the placenta via the oral route. To test this idea, we administered 1x10 6 or 1x10 8 CFU of R. insidiosa to pregnant wild-type (C57BL/6) mice at gestational day 15.5. This strain of mice delivers at 19 days 52 , so this would be roughly equivalent to 32 weeks' gestation in human pregnancy, a time when we detected R. insidiosa in human BP biopsies (Figure 4 B) . We sacrificed the dams at gestational day 18.5 (Figure 4 C) . However, we were unable to detect measurable R. insidiosa CFUs in the uteri/myometrium (UT/MYO), fetal membranes (FM), or placentas (PL). We observed no significant differences in placental weight, fetal weight, fetal width, or fetal length between control mice and those that were administered R. insidiosa (Figure S4 A). Further, none of the mice that received bacteria delivered early (Figure 4 H) . Thus, R. insidiosa administered orally did not adversely affect delivery.
Intrauterine bacterial colonization is associated with preterm birth 53 . Thus, we asked whether R. insidiosa delivered directly to the uterus would colonize the placenta and possibly lead to preterm labor. At day 15.5, pregnant dams were administered two intrauterine injections totaling 1X10 3 CFUs and were monitored for signs of labor until day 18.5. Dams were sacrificed at 18.5 and the UT/MYO, FM, and PL were collected and assessed for CFUs (Figure 4 C) . We were able to recover 1X10 6 to 1X10 7 R. insidiosa from all of these tissues (Figure 4 (Figure S4 B) . Together, these findings suggest that R. insidiosa may reach the placenta via the intrauterine route but that it does not cause any adverse pregnancy outcomes on its own.
Discussion
Whether there are microbiota (live or simply DNA signatures) in the maternal-fetal interface remains mired in controversy. In the recent years, there has been a large number of studies, providing both sequencing and histological evidence, indicating microbial signatures 3, 11, 18, 19, 22, 23, 29 , while other studies have reported these signatures as likely DNA contaminants originating from the sample collection and/or the DNA extraction process, rather than the placenta itself [54] [55] [56] [57] . Placenta location remains a key variable in the aforementioned studies given that that BP, PV and FM have distinct physiology and function. However, many studies interrogating the placental microbiota have not focused on the BP itself, home to fetal EVTs and immune cells. Rather, many studies have focused on either the PV alone, which is in direct contact with maternal blood and the site of nutritional transport and gas exchange, or do not distinguish between the BP and PV when sampling.
We found a high prevalence of R. insidiosa, a waterborne environmental bacterium, in human BPs using multi-variable region 16S sequencing approach 19 . Other investigators have also identified Ralstonia spp. in the placenta 25, 58 and amniotic fluid 3 .
However, some studies suggest Ralstonia. spp. detected by sequencing represent contaminants originating from DNA extraction kits or other sources [54] [55] [56] 58, 59 . In this report, we identify R. insidiosa as a bona fide resident at the maternal-fetal interface by using species-specific FISH probes to confirm and localize R. insidiosa within BP tissue specimens at term.
A recent study from Theis and colleagues provide guidelines for how to define placental microbiota 58 . First, specimens must demonstrate a distinct microbial signal compared to negative controls in order to exclude contamination as the source of bacterial DNA. In our previous study, we employed a series of pre-and post-16S sequencing steps to minimize risk of analyzing false microbial signals 19 . Using 16S qPCR, for example, we detected microbial signals above background and only analyzed the microbial composition of those samples. Using species-specific qPCR we also demonstrated the presence of R. insidiosa DNA in the BP and verified its absence in negative controls 19 .
Second, the guidelines recommend that the detected microbial signals must be validated using multiple methods 58 . In the current study, we present the first use of R.
insidiosa-specific probes to localize the bacteria intracellularly within term human BP specimens, which we previously established were positive for R. insidiosa by 16S sequencing and species-specific qPCR 19 . These probes predominately bind to 16S rRNA and the bright staining suggests a large intact rRNA pool, which is typically a hallmark of viability. Finally, the guidelines suggest that it must be "ecologically plausible" for the detected microbes to reside in the placenta 3, 58 . In this report, we show that R. insidiosa replicates within human placental samples, human BP explants cultured ex vivo, and EVT-like JEG-3 cells in culture. Further, intracellular R. insidiosa bacteria were found in single-membrane bound compartments that closely resembled Spacious Listeriacontaining vacuoles (SLAPs) 60 or Listeria-containing vacuoles (LisCVs) 46 . Using JEG-3 cells, Kortebi et al., showed that L. monocytogenes persist in LisCVs, which are a unique, acidic vacuolar compartments that are not degradative 46 . In JEG-3 cells, we observed R.
insidiosa within clusters or individually within each vacuolar compartment. We speculate that R. insidiosa may also utilize similar non-degradative compartments to adopt a "quiescent lifestyle" 46 within EVTs. Consistent with this, we found R. insidiosa is not harmful to EVTs as it does not induce responses associated with pathogenicityincluding cell death or heightened pro-inflammatory responses.
How R. insidiosa may reside in EVTs remains elusive. We previously showed that uropathogenic E. coli (UPEC) persists in bladder epithelial cells by co-opting the feritinophagy pathway and utilizing bioavailable iron for intracellular growth 61 . Similar to UPEC, some Ralstonia spp., including specific strains of R. picketti 62 and R. eutropha 63 , either demonstrate siderophore activity or harbor gene clusters with putative siderophore functions, suggesting that they have the capacity to chelate iron for growth. However, it is not clear whether R. insidiosa triggers autophagy or scavenges intracellular iron in order to persist in EVTs. Further studies are needed to determine the molecular mechanisms by which R. insidiosa resides in EVTs.
Ralstonia spp. are native to aqueous environments and have been isolated from variety water sources consumed by humans 35 . Using human microbiome database, we showed that Ralstonia spp. are detectable in a variety of oral niches. However, we were not able to cultivate or detect R. insidiosa from placentas by this route. Notably, mouse studies that have traced oral bacteria to the placenta have used intravenous injections (such as tail vein injections) as a method of bacterial administration to model the bloodstream as a source of intrauterine and placental colonization 48, 49 . It is possible that R. insidiosa need to enter maternal circulation to access the placenta. Our results suggest that R. insidiosa did not enter the bloodstream when administered directly to the stomach via oral gavage. However, it is possible that R. insidiosa was able to traffic to the placenta via the oral route in extremely low amounts, but was undetectable using our cultivation methods.
Our studies provide the first in vivo evidence that viable R. insidiosa colonize and replicate within the murine placenta following a local administration via intrauterine injection. LPS alone administered by intrauterine injection at the similar gestational ages (14.5 to 15.5) has been shown to induce preterm labor (delivery at < 19 days) 64 . We show that R. insidiosa, a gram-negative bacterium harboring LPS, does not induce preterm labor. Together, this demonstrates that presence R. insidiosa at the later stages of pregnancy is not associated with adverse pregnancy outcomes.
Using pregnant ewes, Zarate and colleagues recently demonstrated that maternal and/or fetal hypoxic stress later in pregnancy upregulates neuro-immune pathways associated with LPS stimulation 65 . Under these conditions, this group detected live antibiotic-resistant Staphylococcus simulans in the placenta and fetal brain, suggesting that specific physiological changes associated with hypoxic stress, such as increased blood flow and barrier permeability, can promote the passage of maternal bacteria across the placenta and fetal blood-brain barrier 65 . Similarly, maternal stress levels or other unknown physiological changes during pregnancy may explain the presence of R. insidiosa in the human placenta. As suggested by Zarate and colleagues, maternal antibiotic administration may also contribute to the transit of antibiotic resistant bacteria to the placenta. Thus, future studies must address how both external factors and maternal physiology lead to the presence of R. insidiosa in this niche.
In sum, our data indicate that it is ecologically plausible for R. insidiosa to be a bona fide placental microbial resident because it exists intracellularly within BP without causing adverse responses (ie. inflammation and cell death) and may translocate from the uterus to the placenta without inducing preterm birth.
Materials and methods
Study approval
This study was approved by the Washington University School of Medicine human studies review board (IRB ID 201012734) as described in 19, 41, 66 . Informed consent was retrieved from all subjects used in this study. All animal procedures were reviewed and approved by the animal studies committee of the Washington University School of Medicine. 
Species-specific oligonucleotide probe design and specificity evaluation
Placental BP specimens
Our previous study showed that 17 term cases had greater than 300 reads for R. insidiosa 19 and 11 of these cases were used for this study (Median = 2125 reads, IQR =1011 reads). BP biopsies from these cases were formalin-fixed at the time of delivery and paraffin embedded. A total 42 tissue sections were hybridized with R. insidiosa-FITC and EUB338-CY3 probes, 7 of which (n = 2 cases) were used as negative controls and were derived from cases with no detectable R. insidiosa by 16S sequencing. Sections were occasionally tested in parallel with the non-specific NON-EUB338 probe to ensure probe specificity. Subjective observation based on signal intensity and the overlap of the species-specific and eubacterial probe was used to detect the R. insidiosa signal.
Additionally, sections underwent H&E staining as described in 23 .
Bacterial strains and growth kinetics
R. insidiosa strain MJ602 was isolated from the International Space Station potable water reclamation system and is stocked at the Johnson Space Center as R. insidiosa 130770013-1 69 . The YFP-expressing R. insidiosa strain GGW102 was generated by attTn7 integration into MJ602 using co-electroporation of pUC18T-mini-Tn7T-Tp-eyfp (DQ493883) and pTNS2 (AY884833) followed by selection on LB agar with 100 g/ml trimethoprim using the strategy described in 70 insidiosa from the glycerol stocks were streaked onto R2A using a sterile loop and grown at 32 °C until small white round colonies formed. Single colonies were grown in R2B at 32 °C for the appropriate incubation periods. For growth curves of each strain, the optical density at 600 nm (OD600) was recorded every 4 hours over a 24-hour incubation period (n=6 colonies). Colonies grown on R2A and incubated at 32 °C overnight was used to enumerate colony-forming units (CFUs). To calculate CFUs, the following equation was employed: number of colonies x dilution factor/volume on the culture plate. Finally, CFUs were log-transformed and plotted against time or OD600 for each strain. L. monocytogenes was cultured as described in 41 .
BP explant culture
Placentas (n= 5) from term pregnancies delivered by vaginal or Caesarean section were collected within 1-4 hours of delivery and cultured as described previously 41 with the following modifications: BP explants were seeded on to either collagen I-coated 12-well plates and cultured in 1 ml of culture medium (DMEM with 10% fetal bovine serum) or 24-well plates and cultured in 0.5 ml of culture medium. Explants were challenged with 1x10 8 colony forming units of R. insidiosa (GGW102) and centrifuged at 1500 RPM for 5 minutes followed by incubation for 8 hours. To quantify adhered and/or invaded bacteria, media was removed from each well and washed with sterile PBS. Explants from each well and time point were weighed and homogenized in 400 µL of PBS and plated on R2A.
The log-transformed median CFU/g per well was calculated and plotted against time.
Alternatively, explants were fixed in 4% paraformaldehyde (Fisher Scientific, Fair Lawn NJ) at 37 °C for 30 minutes to 1 hour and embedded in 2% agar (Sigma, St. Louis MO).
Explants were processed in 3-5 micron sections. Sections underwent H&E staining, immunofluorescence, and fluorescent in situ hybridization.
Fluorescent in situ hybridization
FPPE sections of placental BP biopsies and cultured explants were deparaffinized and hydrated. Sections were microwaved in 10 mM sodium citrate for 30 minutes at high temperature. Slides were cooled and washed with 2X saline sodium citrate (SSC). Tissues were pretreated with 3 g/ml proteinase K in 0.2 N hydrochloric acid for 10 minutes at 37 °C and washed with 2X SSC. Tissues were treated with lysozyme (2 mg/ml) for 30 minutes at 37 °C and incubated with 0.1% Triton-X-100 in PBS for 5 minutes at room temperature as done in 71 
Immunofluorescence, transmission electron microscopy, and brightfield
Formalin-fixed paraffin embedded (FPPE) term BP biopsies and cultured explants challenged with R. insidiosa were processed in 3-5 micron sections and underwent H&E as described previously. Immunofluorescence staining was performed as described in 41, 72 with a mouse monoclonal antibody to HLA-G (1:500, Santa Cruz Biotechnology, Santa Cruz CA) and a species-specific Alexa Fluor -594. Sections and cells were imaged using the Zeiss confocal microscope using 40x -63x oil immersion. H&E stains of BP biopsies, cultured explants, and mouse placentas were imaged using the brightfield setting of the pathology slide scanner, Nanozoomer (Hamamatsu Photonics), or the 
JEG-3 adherence and invasion assay
JEG-3 cells were obtained from ATCC (HB-36) and cultured as described in 73 .
Cells were challenged with MJ602 at a multiplicity of infection of 0.01, 0.1, and 1. Plates were centrifuged at 1500 RPM for 5 minutes and incubated for 8h. At each MOI, wells were washed three times with warm sterile PBS. Percent adherence and invasion was determined as described in 74 with the following modifications: to quantify cellular adherence and invasion of bacteria, wells were scraped in 900 µL of PBS and placed in a centrifuge tube. 100 µL of 1% Triton-X-100 was added to cells, incubated, and then homogenized through gentle pipetting. Total bacteria per well was determined by adding sterile PBS to wells up to a volume of 900 L, which was followed by the addition of 100 µL of 1% Triton-X for 10 minutes. Cells in the well were homogenized through gentle pipetting. Homogenates were serially diluted and plated onto R2A and incubated at 32 °C overnight. CFUs for adhered and invaded bacteria and total bacteria were completed in triplicate for each MOI. Percent bacterial adherence and invasion was calculated as follows: CFUs of adhered / CFUs of total bacteria x 100 (n=4). Table S3 . R. insidiosa-specific PCR primer pairs (5'-3') were published previously and include the forward primer Rp-F1 (ATGATCTAGCTTGCTAGATTGAT) 76 and the reverse primer R38R1
Lactate dehydrogenase (LDH) assay
(CACACCTAATATTAGTAAGTGCG) 33 . Primers were generated commercially insidiosa-challenged JEG-3 cells was determined at each MOI.
Cytokine Secretion
Media collected post-R. insidiosa challenge (for 8 hours at an MOI 0, 0.01, 0.1, and 1) were profiled for pro-inflammatory cytokines including IL-6, IL-8, and TNF-α using the Milliplex Map Kit Human Cytokine/Chemokine Magnetic Bead Panel (EMD Millipore, Billerica). The procedure was followed according to the manufacturer's instructions.
Human Microbiome Project (HMP) dataset
The HMP Community Profile data page provides 16S sequencing datasets sampled from multiple body sites from healthy individuals. We opted to use the 
Mouse experiments
Vaginal CFUs of were administered to the uterus with a 1 mL syringe at two sites between 1 st and 2 nd fetus. 50 µL was administered at each injection site, without entering the amniotic cavity. Dams were allowed to recover following routine closure with absorbable Vicryl for peritoneal cavity ligation. SHAM-operated mice were used as controls for intrauterine injected mice (n=3). Pregnant dams were monitored for signs of labor and sacrificed at day 18.5 if there were no signs of labor. Upon sacrifice, pregnancy tissues were collected including uteri and myometria, placentas, and fetal membranes. Feto-placental units were underwent formalin-fixation and paraffin embedding or were formalin-fixed and frozen as described previously. Additionally, placental weight, fetal length, fetal width, and fetal weight were determined and fetal membranes, placentas, and uteri/myometria were quantified for CFU/g.
Recovery and detection of R. insidiosa in the tissues of challenged mice
Placentas, fetal membranes, and uteri/myometria were collected from feto- 
